ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Pfizer CDR CAD Hedged

Pfizer CDR CAD Hedged (PFE)

12.22
0.27
(2.26%)
終了 12月22日 6:00AM
リアルタイムデータ

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
12.22
買値
12.15
売値
12.36
出来高
112,006
11.95 日の範囲 12.28
0.00 52 週間の範囲 0.00
前日終値
11.95
始値
11.95
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

PFE 最新ニュース

U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer

BRAFTOVI in combination with cetuximab and mFOLFOX6 is the first and only combination regimen with targeted therapy approved for use as early as first-line for patients with metastatic...

Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EST on Tuesday, February 4, 2025. The...

Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance

Full-Year 2025 Revenue Guidance(1) Range of $61.0 to $64.0 Billion Full-Year 2025 Adjusted(2) Diluted EPS Guidance Range of $2.80 to $3.00 Expect Full-Year 2025 Adjusted(2) Diluted EPS...

Pfizer Declares First-Quarter 2025 Dividend

Board of Directors approves increase in quarterly cash dividend to $0.43 per share Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash...

Pfizer’s IBRANCE® in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer

IBRANCE is the first CDK4/6 inhibitor to show benefit in a large Phase 3 trial in first-line HR+, HER2+ metastatic breast cancer, in combination with anti-HER2 and endocrine therapy Pfizer Inc...

Pfizer Invites Public to View and Listen to Webcast of December 17 Conference Call with Analysts to Provide Full-Year 2025 Financial Guidance

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:30 a.m. EST on Tuesday, December 17, 2024. The...

Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium

– Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients previously treated with a CDK4/6...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

PFE - Frequently Asked Questions (FAQ)

What is the current Pfizer CDR CAD Hedged share price?
The current share price of Pfizer CDR CAD Hedged is $ 12.22
What is the 1 year trading range for Pfizer CDR CAD Hedged share price?
Pfizer CDR CAD Hedged has traded in the range of $ 0.00 to $ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
GRAMGold Flora Corporation
$ 0.025
(66.67%)
262.62k
LITSLithos Energy Ltd
$ 0.035
(16.67%)
450.44k
GLAS.A.UGlass House Brands Inc
US$ 6.38
(14.34%)
28.83k
DEFIValour Inc
$ 4.04
(11.60%)
1.55M
BCBNBase Carbon Inc
$ 0.435
(10.13%)
331.91k
TILTTILT Holdings Inc
$ 0.005
(-50.00%)
336.55k
MAXQMaritime Launch Services Inc
$ 0.05
(-9.09%)
20.29k
JET.BGlobal Crossing Airlines Group Inc
$ 0.57
(-8.06%)
1.66k
DMETDenarius Metals Corp
$ 0.57
(-6.56%)
500
MLCMount Logan Capital Inc
$ 2.25
(-6.25%)
234.6k
CBSTCannabist Company Holdings Inc
$ 0.075
(0.00%)
1.65M
BTQBTQ Technologies Corp
$ 2.95
(2.79%)
1.58M
DEFIValour Inc
$ 4.04
(11.60%)
1.55M
MLMMcfarlane Lake Mining Limited
$ 0.02
(0.00%)
791k
VERSVerses AI Inc
$ 1.13
(0.89%)
714.17k

PFE Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock